Tri-Cira Lo 21 0.025 mg (Ethinyl Estradiol TABLET) 0.025 MG

TRI-CIRA LO 21 0.025 MG tablets contain ethinyl estradiol, a synthetic estrogen used for hormonal contraception and managing menstrual disorders. This oral medication is designed for women seeking reliable birth control and cycle regulation.

Strength

0.025 MG

Pack Size

Manufacturer / TM Owner

APOTEX INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TRI-CIRA LO 21 0.025 MG tablets are primarily used for contraception and managing menstrual irregularities. Ethinyl estradiol, the active ingredient, helps prevent ovulation and regulate menstrual cycles. This medication is often prescribed to women who require hormonal birth control and need to address issues like heavy or irregular periods.

Side Effects

Common effects of TRI-CIRA LO 21 0.025 MG tablets may include changes in menstrual bleeding patterns, breast tenderness, and mild nausea. Some users may experience mood swings or headaches. These effects vary among individuals and typically subside as the body adjusts to the medication.

Precautions & Warnings

TRI-CIRA LO 21 0.025 MG tablets should be used with caution in individuals with a history of blood clots, high blood pressure, or liver disease. It is important to discuss your medical history with a healthcare provider before starting this medication. Regular follow-ups are recommended to monitor for any adverse effects.

Avoid Interactions

TRI-CIRA LO 21 0.025 MG tablets may interact with certain medications, including antibiotics, anticonvulsants, and antifungal drugs. Alcohol consumption should be moderated, as it can increase the risk of side effects. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

TRI-CIRA LO 21 0.025 MG tablets are used for hormonal contraception and managing menstrual disorders. They help prevent ovulation and regulate menstrual cycles.

TRI-CIRA LO 21 0.025 MG tablets are taken orally, typically once daily. Follow the dosage instructions provided by your healthcare provider.

Common side effects may include changes in menstrual bleeding, breast tenderness, nausea, mood swings, and headaches.

TRI-CIRA LO 21 0.025 MG may interact with certain medications, including antibiotics, anticonvulsants, and antifungal drugs. Consult your healthcare provider before combining with other treatments.

TRI-CIRA LO 21 0.025 MG should be used with caution in individuals with a history of blood clots, high blood pressure, or liver disease. Always consult a healthcare provider before starting this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.